Taking high doses of statins including simvastatin, atorvastatin or rosuvastatin could drastically increase the risk of being hospitalized for kidney damage, says a study from researchers at the Lady Davis Institute for Medical Research in Quebec.
For the study the researchers reviewed health records from roughly two million Canadian citizens. They found that those who were hospitalized for acute kidney injury (AKI) were 34 percent more likely to be taking a high dosage of any statin.
Lead researcher Professor Donal O'Donoghue said those beginning a statin treatment should be especially aware of their kidneys:
"Every person on a statin needs careful assessment of their AKI risk. We know AKI occurs in over half a million people in the U.K. each year. At least 1 in 5 are due to medicines. This costs the NHS £1.3 billion per year. This new study shows the need to 'think kidney' when drugs are prescribed. In England there are over 55,000 excess deaths per year due to AKI - at least 12,000 are unnecessary."
For comments and feedback contact: editorial@rttnews.com
Health News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.